FDA Clears Second-Generation AcQMap 3D EP Imaging and Mapping Catheter
September 29, 2020
FDA Clears Second-Generation AcQMap 3D EP Imaging and Mapping Catheter
September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of…
Read More
September 29, 2020
ECMO Support Found Effective in Sickest of COVID-19 Patients
September 29, 2020 –  Extracorporeal membrane oxygenation (ECMO) support saved lives in past epidemics of lung-damaging…
Read More
The artificial intelligence-driven Caption Guidance software guides point of care ultrasound (POCUS) users to get optimal cardiac ultrasound images. The AI software is an example of a FDA-cleared software that is helping improve imaging, even when used by less experienced users.
Joe Fornadel, J.D., and Wes Moran, J.D.
September 29, 2020
Recent Developments in Artificial Intelligence and Accompanying Liability Risks
The number of Federal Drug Administration (FDA)-approved AI-based algorithms is significant and has grown at a steady…
Read More
Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original Acurate neo platform. Compared to the previous generation device, the Acurate neo2 valve system also has an expanded indication for patients with aortic stenosis. #TAVR #TAVI
September 29, 2020
Boston Scientific Launches Acurate neo2 Transcatheter Aortic Valve System in Europe
September 29, 2020 — Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system…
Read More
hort-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 (SARS-CoV-2) who are risk assessed prior to receiving the drug. That is the finding of research published today in EP Europace, a journal of the European Society of Cardiology (ESC). #COVID19 #SARSCoV2 #hydroxychloroquine
September 25, 2020
Short-term Hydroxychloroquine Use in COVID-19 Patients Does Not Cause Lethal Arrhythmias if Screened
September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients…
Read More
The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 
September 25, 2020
VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study
September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the…
Read More
Philips introduced the QuickClear Mechanical Thrombectomy System. It is a simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system.
September 25, 2020
Philips Introduces QuickClear Mechanical Thrombectomy System for Blood Clot Removal
September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use…
Read More
EchoGo Pro automates cardiac ultrasound measurements for heart functions, but also empower physicians to predict the occurrence of coronary artery disease (CAD).
September 25, 2020
Ultromics Earns Frost & Sullivan Innovation Award for Pioneering AI-based Cardiac Echo Software
September 25, 2020 — Based on its recent analysis of the global artificial intelligence (AI)-based echocardiography…
Read More
An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Philips Healthcare.
September 25, 2020
Study Finds Removing Cost from Calcium Score Testing Increased Utilization
September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary artery…
Read More
SARS-CoV-2 infection of cells shown in green, left. This is inhibited by a modified form of cholesterol called 25-hydroxycholesterol (25HC), as seen in the cells in the right image. 25HC activates an enzyme called ACAT, found inside cells in the endoplasmic reticulum. ACAT then depletes accessible cholesterol on the cell’s membrane. It is a normally occurring process that gets kicked into high gear during some viral infections. Image from UC San Diego Health Sciences.
September 24, 2020
Statins May Reduce COVID-19 Severity
September 24, 2020 — Analyzing anonymized patient medical records, University of California (UC) San Diego Health…
Read More
Fitbit Sense is the company’s first device compatible with an ECG app that enables users to take a spot check reading of their heart that can be analyzed for the heart rhythm irregularity atrial fibrillation (AFib).
September 24, 2020
Fitbit ECG App to Identify Atrial Fibrillation Receives Regulatory Clearance in U.S. and Europe 
September 24, 2020 — Fitbit received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as…
Read More
The Optimizer Smart System is a pacemaker-like device that improves heart function and reduces debilitating symptoms associated with the disease, including fatigue and shortness of breath.
September 23, 2020
Allegheny General Hospital Cardiologists First in the Region to Use Novel Implantable Device to Treat Heart Failure
September 23, 2020 – A team of cardiologists at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN…
Read More
The Farapulse pulsed field ablation (PFA) system, also referred to as electroporation, ablates heart tissue using the creation of an electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation.
September 23, 2020
Boston Scientific Invests in Pulsed Field Ablation Technology To Improve Atrial Fibrillation Therapy
September 23, 2020 — Boston Scientific Corp. signed an investment agreement with an exclusive option to acquire…
Read More
COVID-19 Therapy Drug Azithromycin May Increase Risk for Cardiac Events
September 17, 2020
COVID-19 Therapy Drug Azithromycin May Increase Risk for Cardiac Events
September 17, 2020 — Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of…
Read More
Explanation of optical coherence imaging (OCT) coronary imaging.
Aziz Maksoud M.D., FACC, FSCAI, and Bassem Chehab, M.D., FACC, FSCAI
September 17, 2020
Value of OCT in the Cath Lab Shown in Early Results of LightLab Initiative 
Although not a new technology, optical coherence tomography (OCT) is the dark horse of imaging that could give…
Read More
Naples Community Hospital Director of Cardiac Imaging Bill Shirkey showing a point-of-care echocardiogram of a COVID-19 patient he imaged with a GE Healthcare Vscan device bedside in an isolation room. Use of a small handheld device greatly speeds disinfection after the exam and does not require moving a larger cart-based ultrasound system into a room, which may require moving furniture and add exposure time in the room.
September 15, 2020
Handheld Ultrasound Helps to Monitor COVID-19 Patients With Cardiac Conditions
September 15, 2020 — The world is facing a global pandemic with unknown implications, but is now well known COVID-19 (…
Read More
The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.
September 15, 2020
Philips Expands Cardiovascular Ultrasound With Affiniti CVx to Increase Productivity
September 15, 2020 — Philips Healthcare recently introduced the latest addition to its portfolio of dedicated…
Read More
Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.
September 14, 2020
Emerging Technology and Data Key to Closing Treatment Gaps to Improve Cardiovascular Care
September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular…
Read More
Exantham on abdomen and back of a pediatric patient at Nemours Children’s Health System in Delaware who presented with mysterious symptoms in what would later be identified as one of the first cases of multisystem inflammatory syndrome in children (MIS-C) in the United States.
September 14, 2020
Case Study Describes One of the First U.S. Cases of MIS-C
September 14, 2020 – At the height of the COVID-19 (SAR-CoV-2) pandemic in April, a 14-year-old boy was admitted to the…
Read More
September 14, 2020
FDA Clears TigerEye Image-guided CTO Crossing System
September 14, 2020 — Avinger received U.S. Food and Drug Administration (FDA) 510(k) clearance from the FDA for its…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now